Search results
We did not find results for: excision biotherapeutics july 2023.
Check spelling or type a new query.
We did not find results for: excision biotherapeutics july 2023.
Check spelling or type a new query.
Clinical-stage biotechnology company
Excision BioTherapeutics is a biopharmaceutical company based in San Francisco focused on developing gene therapies against HIV infection. The company has a single, CRISPR–Cas9 based therapy, EBT-101, under investigation. Initial investigation into the therapy was conducted by the lab of Kamel Khalili, a professor at Temple University. In July, 2023 the US Food and Drug Administration granted EBT-... Wikipedia